Breast Biopsy Market Forecast and Growth Drivers
The Breast Biopsy Market is poised for robust growth, expected to advance significantly from a market size of approximately USD 1.53 billion in 2023 to an estimated USD 2.50 billion by 2035, registering a CAGR of around 4.17%, as projected by MRFR. This growth is underpinned by expanding breast cancer screening programs, rising awareness about early detection, and growing adoption of minimally invasive biopsy techniques. Innovations in device design and imaging guidance are promoting adoption across hospitals, diagnostic centers, and specialty clinics. Moreover, favorable healthcare policies and investments in oncology infrastructure across both developed and emerging markets are buoying the market outlook.